{"id":32544,"date":"2025-04-27T18:39:31","date_gmt":"2025-04-27T10:39:31","guid":{"rendered":"https:\/\/flcube.com\/?p=32544"},"modified":"2025-04-27T18:39:31","modified_gmt":"2025-04-27T10:39:31","slug":"merck-q1-2025-results-keytruda-sales-grow-6-despite-gardasil-dip-in-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=32544","title":{"rendered":"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China"},"content":{"rendered":"\n<p>Global pharmaceutical company Merck (<a href=\"https:\/\/www.google.com\/finance\/quote\/MRK:NYSE\">NYSE: MRK<\/a>) released its Q1 2025 financial results, showing total sales increased by 1% year-on-year in constant currency terms to USD 15.53 billion. Pharmaceutical sales, however, decreased by -1% YOY to USD 13.64 billion. The decline was primarily due to falling demand in China for Gardasil, Merck\u2019s human papillomavirus (HPV) vaccine, which saw global sales drop by -40% to USD 1.33 billion. Excluding Gardasil\u2019s impact, Merck\u2019s global sales grew by 8% YOY.<\/p>\n\n\n\n<p><strong>Key Drug Performances<\/strong><br>The world\u2019s top-selling drug in 2024, Keytruda (pembrolizumab), a programmed death-1 (PD-1) inhibitor, posted relatively subdued growth of 6% YOY to USD 7.2 billion. Januvia\/Janumet (sitagliptin), a Type 2 diabetes drug, saw sales grow by 21% to USD 796 million. Winrevair (sotatercept), a newly launched pulmonary arterial hypertension (PAH) therapy, achieved USD 280 million in sales. Meanwhile, pediatric vaccines ProQuad, MMRII, and VariVax saw a -5% dip to USD 539 million.<\/p>\n\n\n\n<p><strong>Financial Adjustments<\/strong><br>Merck maintained its outlook for full-year 2025 sales at USD 64.1 billion to USD 65.6 billion. However, the non-GAAP earnings per share (EPS) forecast was adjusted downwards to USD 8.82 to USD 8.97. This revision reflects the USD 200 million upfront payment made to China-based Jiangsu Hengrui Medicine in a March 2025 deal valued at up to USD 1.97 billion for ex-China rights to the lipoprotein(a) (Lp(a)) inhibitor HRS-5346. Additionally, MSD noted an expected USD 200 million increase in annual operating costs due to tariffs imposed by the US and Chinese governments.<\/p>\n\n\n\n<p><strong>Tariffs Impact<\/strong><br>CEO Rob Davis highlighted during the earnings conference call that MSD is well-prepared for potential tariffs against the pharma sector. He emphasized that MSD has been investing in its supply chain since 2017, aiming to achieve regionalized manufacturing capabilities. \u201cWe\u2019ve invested USD 12 billion in expanding our manufacturing footprint since the TCJA and expect to spend an additional USD 9-plus billion,\u201d said Davis.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/Q1-2025_Earnings_Infographic_MRK.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of Q1-2025_Earnings_Infographic_MRK.\"><\/object><a id=\"wp-block-file--media-8560d653-f2fb-45ef-af6e-fb16384439a0\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/Q1-2025_Earnings_Infographic_MRK.pdf\">Q1-2025_Earnings_Infographic_MRK<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/Q1-2025_Earnings_Infographic_MRK.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-8560d653-f2fb-45ef-af6e-fb16384439a0\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Global pharmaceutical company Merck (NYSE: MRK) released its Q1 2025 financial results, showing total sales&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32547,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[39,20,27,108,120,903,18,68,12],"class_list":["post-32544","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-diabetes","tag-finance","tag-finanical-reports","tag-high-blood-pressure","tag-merck","tag-nyse-mrk","tag-pd-1-l1","tag-pediatric-drugs","tag-vaccine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Global pharmaceutical company Merck (NYSE: MRK) released its Q1 2025 financial results, showing total sales increased by 1% year-on-year in constant currency terms to USD 15.53 billion. Pharmaceutical sales, however, decreased by -1% YOY to USD 13.64 billion. The decline was primarily due to falling demand in China for Gardasil, Merck\u2019s human papillomavirus (HPV) vaccine, which saw global sales drop by -40% to USD 1.33 billion. Excluding Gardasil\u2019s impact, Merck\u2019s global sales grew by 8% YOY.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=32544\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=32544\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-27T10:39:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China\",\"datePublished\":\"2025-04-27T10:39:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544\"},\"wordCount\":313,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2717.webp\",\"keywords\":[\"Diabetes\",\"Finance\",\"Finanical Reports\",\"High blood pressure\",\"Merck\",\"NYSE: MRK\",\"PD-1\\\/L1\",\"Pediatric drugs\",\"Vaccine\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32544#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=32544\",\"name\":\"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2717.webp\",\"datePublished\":\"2025-04-27T10:39:31+00:00\",\"description\":\"Global pharmaceutical company Merck (NYSE: MRK) released its Q1 2025 financial results, showing total sales increased by 1% year-on-year in constant currency terms to USD 15.53 billion. Pharmaceutical sales, however, decreased by -1% YOY to USD 13.64 billion. The decline was primarily due to falling demand in China for Gardasil, Merck\u2019s human papillomavirus (HPV) vaccine, which saw global sales drop by -40% to USD 1.33 billion. Excluding Gardasil\u2019s impact, Merck\u2019s global sales grew by 8% YOY.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32544\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2717.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2717.webp\",\"width\":1080,\"height\":608,\"caption\":\"Merck & Co. Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32544#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China - Insight, China&#039;s Pharmaceutical Industry","description":"Global pharmaceutical company Merck (NYSE: MRK) released its Q1 2025 financial results, showing total sales increased by 1% year-on-year in constant currency terms to USD 15.53 billion. Pharmaceutical sales, however, decreased by -1% YOY to USD 13.64 billion. The decline was primarily due to falling demand in China for Gardasil, Merck\u2019s human papillomavirus (HPV) vaccine, which saw global sales drop by -40% to USD 1.33 billion. Excluding Gardasil\u2019s impact, Merck\u2019s global sales grew by 8% YOY.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=32544","og_locale":"en_US","og_type":"article","og_title":"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=32544","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-27T10:39:31+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=32544#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=32544"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China","datePublished":"2025-04-27T10:39:31+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=32544"},"wordCount":313,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=32544#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp","keywords":["Diabetes","Finance","Finanical Reports","High blood pressure","Merck","NYSE: MRK","PD-1\/L1","Pediatric drugs","Vaccine"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=32544#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=32544","url":"https:\/\/flcube.com\/?p=32544","name":"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=32544#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=32544#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp","datePublished":"2025-04-27T10:39:31+00:00","description":"Global pharmaceutical company Merck (NYSE: MRK) released its Q1 2025 financial results, showing total sales increased by 1% year-on-year in constant currency terms to USD 15.53 billion. Pharmaceutical sales, however, decreased by -1% YOY to USD 13.64 billion. The decline was primarily due to falling demand in China for Gardasil, Merck\u2019s human papillomavirus (HPV) vaccine, which saw global sales drop by -40% to USD 1.33 billion. Excluding Gardasil\u2019s impact, Merck\u2019s global sales grew by 8% YOY.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=32544#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=32544"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=32544#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp","width":1080,"height":608,"caption":"Merck & Co. Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=32544#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2717.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32544"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32544\/revisions"}],"predecessor-version":[{"id":32548,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32544\/revisions\/32548"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/32547"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}